Status:
COMPLETED
Cardiovascular Function in Adult Survivors of Childhood Malignancies
Lead Sponsor:
The University of Hong Kong
Conditions:
Childhood Cancers
Eligibility:
All Genders
18-35 years
Brief Summary
Anthracyclines have been used commonly to treat children with solid tumours and haematological malignancies and have led to their increased survival. Nonetheless, anthracycline has the side effect of ...
Detailed Description
Incorporation of anthracyclines into chemotherapy protocols has improved the survival of children with solid tumours and haematological malignancies. Nonetheless, longitudinal studies have implicated ...
Eligibility Criteria
Inclusion
- patients aged 18 to 35 years old
- history of acute leukaemia diagnosed before 18 years old
- completion of cancer directed therapy for at least 5 years.
Exclusion
- history of congenital heart disease
- presence of syndromal disorder such as Down syndrome, neurofibromatosis, etc,
- hypothyroidism not on replacement therapy
- claustrophobia or other reasons rendering MRI assessment not feasible.
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT01415999
Start Date
August 1 2011
End Date
July 1 2012
Last Update
October 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong, China